Details for New Drug Application (NDA): 070266
✉ Email this page to a colleague
NDA 070266 describes INDO-LEMMON, which is a drug marketed by Teva and is included in two NDAs. Additional details are available on the INDO-LEMMON profile page.
The generic ingredient in INDO-LEMMON is indomethacin. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the indomethacin profile page.
The generic ingredient in INDO-LEMMON is indomethacin. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the indomethacin profile page.
Summary for 070266
| Tradename: | INDO-LEMMON |
| Applicant: | Teva |
| Ingredient: | indomethacin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070266
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
| Approval Date: | Nov 7, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
